adalimumab psoriasis
Selected indexed studies
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator-controlled VOYAGE 1 trial. (J Am Acad Dermatol, 2017) [PMID:28057360]
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial. (J Am Acad Dermatol, 2017) [PMID:28057361]
- Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis. (JAMA Dermatol, 2025) [PMID:40465280]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator-controlled VOYAGE 1 trial. (2017) pubmed
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial. (2017) pubmed
- Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis. (2025) pubmed
- Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation. (2020) pubmed
- Adalimumab in Chronic Plaque Psoriasis: A Clinical Guide. (2017) pubmed
- Adalimumab: in plaque psoriasis. (2009) pubmed
- Comparison of adalimumab with methotrexate for psoriasis: A meta-analysis of randomized controlled studies. (2024) pubmed
- Adalimumab for the treatment of psoriasis. (2009) pubmed
- Efficacy of adalimumab in pediatric generalized pustular psoriasis: case series and literature review. (2022) pubmed
- Comparative Efficacy of Deucravacitinib and Adalimumab for Scalp Psoriasis: An Indirect Treatment Comparison. (2025) pubmed